Ferrlecit

Active Ingredient(s): Sodium Ferric Gluconate Complex
FDA Approved: * February 18, 1999
Pharm Company: * WATSON PHARMS
Category: Anemia

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Ferrlecit Overview

Sodium ferric gluconate complex, sold under the brand name Ferrlecit, is an intravenously administered iron medication for the treatment of iron deficiency anemia in adults and in children aged six years and older with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy.[2] The macromolecule has an apparent molecular weight of 289,000 – 440,000 Dalton.[3] The most common side effects in adults are nausea, vomiting ...

Read more Ferrlecit Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Sodium_ferric_gluconate_complex

Recent Ferrlecit Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Sodium Ferric Gluconate Complex
  • Injection: 12.5mg/ml, 62.5mg/5ml, Eq 62.5mg Iron/5ml (eq 12.5mg Iron/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Ferrlecit: (3 results)

Sorted by National Drug Code
  • 0024-2791 Ferrlecit 12.5 mg/ml Intravenous Injection by Sanofi-aventis U.S. LLC
  • 0024-2792 Ferrlecit 12.5 mg/ml Intravenous Injection by Sanofi-aventis U.S. LLC
  • 0024-2794 Ferrlecit 12.5 mg/ml Intravenous Injection by Sanofi-aventis U.S. LLC

Other drugs which contain Sodium Ferric Gluconate Complex or a similar ingredient: (1 result)